Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Cancer Educ. 2021 Feb 4;37(5):1372–1377. doi: 10.1007/s13187-021-01965-9

Table 2.

Predictors of HPV-Related Outcomes

HPV-related outcomes Predictors OR 95% CI p AOR 95% CI p

Heard of HPV
 Age (40+ years) 0.54 0.26–1.11 0.09 0.73 0.32–1.65 0.45
 Samoan 2.87 1.09–7.57 0.03 2.86 0.98–8.37 0.06
 Am Acculturation 1.31 1.10–1.56 0.002 1.26 1.05–1.52 0.02
 Fatalism 0.77 0.59–0.99 0.05 0.85 0.63–1.15 0.29
Heard of HPV Vaccine
 Age (40+ years) 0.53 0.26–1.07 0.08 0.59 0.26–1.35 0.21
 Employed 3.25 1.58–6.66 0.001 2.89 1.27–6.55 0.01
 Tongan 0.27 0.13–0.56 0.00 0.33 0.13–0.83 0.02
 Am Acculturation 1.21 1.03–1.42 0.02 1.14 0.95–1.37 0.16
 Fatalism 0.74 0.57–0.96 0.03 0.97 0.69–1.35 0.84
Would Vaccinate Child
 Age (40+ years) 0.44 0.21–0.91 0.03 0.37 0.17–0.82 0.01
 Am Acculturation 0.86 0.73–1.01 0.06 0.82 0.69–0.98 0.03

Note: Bolded p-values represent statistical significance for the AORs (p≤ 0.05).

Note: Potential predictor variables in the models presented here were: intervention vs. control group, age (40 years and older vs. under age 40), ethnicity (Samoans vs. non-Samoans, Tongans vs. non-Tongans, and Chamorros vs. non-Chamorros), health insurance status, employment status (employed vs. not employed or retired), and scores on PI acculturation, American acculturation, fatalistic attitudes toward cancer, and knowledge about cervical cancer risk factors. Only those predictors that were significantly associated with the given outcome variable in bivariate analyses are included here.